alendronic acid and its Impurities
Alendronic acid was first described in 1978 and approved for medical use in the United States in 1995. Alendronic acid, sold under the brand name Fosamax among others, is a bisphosphonate medication used to treat osteoporosis and Paget's disease of bone. Reference standards of Alendronic Acid API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
